Emotional disorders in patients with Parkinson's disease on the background of the comorbid pathology of autoimmune genesis

Authors

DOI:

https://doi.org/10.15587/2519-4798.2018.132571

Keywords:

Parkinson's disease, autoimmune thyroiditis, affective disorders, depression, anxiety, quality of life

Abstract

Parkinson's disease is one of the most common neurodegenerative diseases, which affects more than 1% of the world's population, is over 65 years old, and the incidence rate can double by 2030. This pathology is accompanied by both motor and non-motor manifestations (NMM). One of the frequent types of affective disorders in patients with PD is depression. Depression can worsen both the motor and social activity of patients with PD. Understanding the factors associated with depressive symptoms contributes to early detection and timely treatment. In a number of studies, depression and anxiety are recognized as a major factor in the poor quality of life of patients with PD.

Aim of the research. To study the features of emotional disorders in patients with Parkinson's disease (PD) and autoimmune thyroiditis (AIT).

Materials and methods. 109 patients with PD at the age from 47 to 75 years were examined. The main group of patients consisted of ІА and ІB subgroups, control group - ІІА and subgroups IIB. Conducted general clinical and neurological examination, assessment of motor functions using the unified PD scores (UPDRS), neuropsychological testing (Becky Depression Rating Scale (BDI), Hamilton Alarm Scale (HARS), PDQ-39 quality of life assessment, statistical analysis with program "Statistica 6.0".

Results. The study showed the presence of depression in 84 patients with PD, which is 77.1%, and anxiety disorders in 73 patients, respectively 67.0%. The analysis of the depression and anxiety index in the dynamics showed a statistically significant difference in the subgroups ІА and ІB. There was a strong statistically significant direct correlation between the scores for the detection of affective disorders and the patient's quality of life indicator (PDQ-39) during the initial examination and a year later in subgroups IA and IB.

Conclusions. There was a statistically significant difference in affective disorders in dynamics in patients with PD and AIT. The influence of the level of anxiety and depression on the quality of life of patients with PD and AIT was revealed, which indicates a high medico-social significance of these disorders

Author Biography

Tetiana Cheboraka, Shupyk National Medical Academy of Postgraduate Education Dorohozhytska str., 9, Kyiv, Ukraine, 04112

Postgraduate student

Department of Neurology No. 1

References

  1. Levin, O. S., Artemyev, D. V., Bril, E. V., Kulua, T. K. (2017). Parkinson’s disease: modern approaches to diagnosis and treatment. Practical medicine, 1 (102), 45–51.
  2. Tarianyk, Ye. A. (2011). Estimation of higher cortex functions in patients with Parkinson’s disease in its different stages. Actual problems of modern medicine. Bulletin of the Ukrainian Medical Stomatological Academy, 2 (11), 159–161.
  3. Chaudhuri, K. R., Schapira, A. H. (2009). Non-motor symptoms of Parkinsons disease: dopaminergic pathophysiology and treatment. The Lancet Neurology, 8 (5), 464–474. doi: 10.1016/s1474-4422(09)70068-7
  4. Barone, P., Antonini, A., Colosimo, C., Marconi, R., Morgante, L., Avarello, T. P. et. al. (2009). The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Movement Disorders, 24 (11), 1641–1649. doi: 10.1002/mds.22643
  5. Global Parkinson's Disease Survey (GPDS) Steering Committee Factors impacting on quality of life in Parkinson's disease: results from an international survey (2002). Movement Disorders, 17 (1), 60–67. doi: 10.1002/mds.10010
  6. Goncharova, Z. A., Rabadanova, E. A., Gelpey, M. A. (2015). Non-motor manifestations of Parkinson’s disease and their influence on quality of patients life. Journal of Fundamental Medicine and Biology, 1, 40–44.
  7. Ross, G. W., Petrovitch, H., Abbott, R. D., Tanner, C. M., Popper, J., Masaki, K. et. al. (2008). Association of olfactory dysfunction with risk for future Parkinson’s disease. Annals of Neurology, 63 (2), 167–173. doi: 10.1002/ana.21291
  8. Chen, H., Burton, E. A., Ross, G. W., Huang, X., Savica, R., Abbott, R. D. et. al. (2013). Research on the Pre-Motor Symptoms of Parkinson’s Disease: Clinical and Etiological Implications. Environmental Health Perspectives, 121, 11–12. doi: 10.1289/ehp.1306967
  9. Heinzel, S., Roeben, B., Ben-Shlomo, Y., Lerche, S., Alves, G., Barone, P. et. al. (2016). Prodromal Markers in Parkinson’s Disease: Limitations in Longitudinal Studies and Lessons Learned. Frontiers in Aging Neuroscience, 8, 147. doi: 10.3389/fnagi.2016.00147
  10. Claassen, D. O., Josephs, K. A., Ahlskog, J. E., Silber, M. H., Tippmann-Peikert, M., Boeve, B. F. (2010). REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology, 75 (6), 494–499. doi: 10.1212/wnl.0b013e3181ec7fac
  11. Gao, J., Huang, X., Park, Y., Hollenbeck, A., Blair, A., Schatzkin, A., Chen, H. (2011). Daytime Napping, Nighttime Sleeping, and Parkinson Disease. American Journal of Epidemiology, 173 (9), 1032–1038. doi: 10.1093/aje/kwq478
  12. Goldstein, D. S. (2010). Neuroscience and heart-brain medicine: The year in review. Cleveland Clinic Journal of Medicine, 77 (3), 34–39. doi: 10.3949/ccjm.77.s3.06
  13. Nodel, M. R. (2010). Depression in Parkinson’s disease. Neurology, neuropsychiatry, psychosomatics, 11–17.
  14. Valkovic, P., Harsany, J., Hanakova, M., Martinkova, J., Benetin, J. (2014). Nonmotor Symptoms in Early- and Advanced-Stage Parkinson's Disease Patients on Dopaminergic Therapy: How Do They Correlate with Quality of Life? ISRN Neurology, 2014. doi: 10.1155/2014/587302
  15. Gallagher, D. A., Lees, A. J., Shrag, A. (2011). What are the most important non-mo-tor symptoms in patients with Parkinsons disease and are we missing them? Movement Disorders, 25 (15), 2493–2500. doi: 10.1002/mds.23394
  16. Nodel, M. R. (2015). The impact of neuropsychiatric symptoms on quality of life of patients with parkinson’s disease. The Neurological Journal, 20 (1), 20–25. doi: 10.18821/1560-9545-2015-20-1-20-27
  17. Liashenko, E. A., Gankin, O. A., Ivanov, L. G., Levin, O. S. (2014). Predictors of cognitive and affective disorders in Parkinson's disease. Zemsky doctor, 3-4 (24), 9–12.

Downloads

Published

2018-05-30

How to Cite

Cheboraka, T. (2018). Emotional disorders in patients with Parkinson’s disease on the background of the comorbid pathology of autoimmune genesis. ScienceRise: Medical Science, (4 (24), 17–23. https://doi.org/10.15587/2519-4798.2018.132571

Issue

No. 4 (24) (2018)

Section

Medical Science

License

Copyright (c) 2018 Tetiana Cheboraka

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.